Azacitidine and Pembrolizumab in Pancreatic Cancer

Clinical trial NCT03264404 · COMPLETED

Trial details

NCT number: NCT03264404
Sponsor: Susan E. Bates
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreas Cancer

Start date: 2017-10-01
Primary completion: 2021-10-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.